The Diabetes and Chronic Kidney Disease program aims to slow progression of CKD leading to end-stage renal disease and other diabetes related complications.
The aims (below) are achieved by partnering with the patient/whanau, sharing matauranga/knowledge, improving self-management skills and strategies, and enabling appropriate treatment intensification.
For people living with suboptimal diabetes (Hbalc greater than 53 mmol/mol) and CKD 3B or earlier (eGFR 30 ml/min and above), please see the referral criteria and pathway in Appendix 1, for guidance (PDF).
Optimise treatment by progressing therapy as appropriate and by improving patient expertise on self-management on the following parameters.
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read moreBoth dulaglutide (Trulicity™) and Liraglutide (Victoza™) can be initiated for new patients who meet the special authority criteria from 1st July 2025.
Read moreThe clinical diabetes specialist in primary care provides clinical mentorship and advice to the practice team in supporting patients with diabetes.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.